Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.
Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Kaplan LD, et al. Among authors: scadden dt. Blood. 2005 Sep 1;106(5):1538-43. doi: 10.1182/blood-2005-04-1437. Epub 2005 May 24. Blood. 2005. PMID: 15914552 Free PMC article. Clinical Trial.
Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.
Mitsuyasu RT, Anton PA, Deeks SG, Scadden DT, Connick E, Downs MT, Bakker A, Roberts MR, June CH, Jalali S, Lin AA, Pennathur-Das R, Hege KM. Mitsuyasu RT, et al. Among authors: scadden dt. Blood. 2000 Aug 1;96(3):785-93. Blood. 2000. PMID: 10910888 Free article. Clinical Trial.
Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B, Scadden D, Kaplan L, Ambinder R, Levine A, Harrington W, Grochow L, Flexner C, Tan B, Straus D; AIDS Malignancy Consortium. Ratner L, et al. J Clin Oncol. 2001 Apr 15;19(8):2171-8. doi: 10.1200/JCO.2001.19.8.2171. J Clin Oncol. 2001. PMID: 11304769 Clinical Trial.
Hematologic Aspects of HIV/AIDS.
Levine AM, Scadden DT, Zaia JA, Krishnan A. Levine AM, et al. Among authors: scadden dt. Hematology Am Soc Hematol Educ Program. 2001:463-78. doi: 10.1182/asheducation-2001.1.463. Hematology Am Soc Hematol Educ Program. 2001. PMID: 11722999 Review.
Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.
Miles SA, Dezube BJ, Lee JY, Krown SE, Fletcher MA, Saville MW, Kaplan L, Groopman J, Scadden DT, Cooley T, Von Roenn J, Friedman-Kien A; AIDS Malignancy Consortium. Miles SA, et al. Among authors: scadden dt. AIDS. 2002 Feb 15;16(3):421-9. doi: 10.1097/00002030-200202150-00014. AIDS. 2002. PMID: 11834954 Clinical Trial.
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
Noy A, Scadden DT, Lee J, Dezube BJ, Aboulafia D, Tulpule A, Walmsley S, Gill P. Noy A, et al. Among authors: scadden dt. J Clin Oncol. 2005 Feb 10;23(5):990-8. doi: 10.1200/JCO.2005.11.043. Epub 2004 Dec 14. J Clin Oncol. 2005. PMID: 15598977 Clinical Trial.
Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.
Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ, Aboulafia DM, Scadden DT. Spitzer TR, et al. Among authors: scadden dt. Biol Blood Marrow Transplant. 2008 Jan;14(1):59-66. doi: 10.1016/j.bbmt.2007.03.014. Biol Blood Marrow Transplant. 2008. PMID: 18158962 Free PMC article. Clinical Trial.
399 results